• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中的缺氧途径:从发病机制到治疗靶点。

Hypoxia Pathways in Parkinson's Disease: From Pathogenesis to Therapeutic Targets.

机构信息

National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.

Department of Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Int J Mol Sci. 2024 Sep 29;25(19):10484. doi: 10.3390/ijms251910484.

DOI:10.3390/ijms251910484
PMID:39408813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11477385/
Abstract

The human brain is highly dependent on oxygen, utilizing approximately 20% of the body's oxygen at rest. Oxygen deprivation to the brain can lead to loss of consciousness within seconds and death within minutes. Recent studies have identified regions of the brain with spontaneous episodic hypoxia, referred to as "hypoxic pockets". Hypoxia can also result from impaired blood flow due to conditions such as heart disease, blood clots, stroke, or hemorrhage, as well as from reduced oxygen intake or excessive oxygen consumption caused by factors like low ambient oxygen, pulmonary diseases, infections, inflammation, and cancer. Severe hypoxia in the brain can manifest symptoms similar to Parkinson's disease (PD), including cerebral edema, mood disturbances, and cognitive impairments. Additionally, the development of PD appears to be closely associated with hypoxia and hypoxic pathways. This review seeks to investigate the molecular interactions between hypoxia and PD, emphasizing the pathological role of hypoxic pathways in PD and exploring their potential as therapeutic targets.

摘要

人脑对氧气高度依赖,在休息时大约消耗身体氧气的 20%。大脑缺氧会导致几秒钟内失去意识,几分钟内死亡。最近的研究已经确定了大脑中存在自发性间歇性缺氧的区域,称为“缺氧口袋”。由于心脏病、血栓、中风或出血等原因导致血流受损,以及由于低环境氧气、肺部疾病、感染、炎症和癌症等因素导致氧气摄入减少或氧气消耗过多,也会导致缺氧。大脑严重缺氧会表现出类似于帕金森病(PD)的症状,包括脑水肿、情绪障碍和认知障碍。此外,PD 的发展似乎与缺氧和缺氧途径密切相关。本综述旨在探讨缺氧与 PD 之间的分子相互作用,强调缺氧途径在 PD 中的病理作用,并探索它们作为治疗靶点的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/11477385/8688a415f2f8/ijms-25-10484-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/11477385/b509eb9dd903/ijms-25-10484-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/11477385/63026b9ac078/ijms-25-10484-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/11477385/60c8be730b86/ijms-25-10484-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/11477385/ac0f1a006fd4/ijms-25-10484-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/11477385/8688a415f2f8/ijms-25-10484-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/11477385/b509eb9dd903/ijms-25-10484-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/11477385/63026b9ac078/ijms-25-10484-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/11477385/60c8be730b86/ijms-25-10484-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/11477385/ac0f1a006fd4/ijms-25-10484-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07fe/11477385/8688a415f2f8/ijms-25-10484-g005.jpg

相似文献

1
Hypoxia Pathways in Parkinson's Disease: From Pathogenesis to Therapeutic Targets.帕金森病中的缺氧途径:从发病机制到治疗靶点。
Int J Mol Sci. 2024 Sep 29;25(19):10484. doi: 10.3390/ijms251910484.
2
The Parkinson's Disease-Associated Mutation LRRK2-G2019S Impairs Synaptic Plasticity in Mouse Hippocampus.与帕金森病相关的突变LRRK2-G2019S损害小鼠海马体中的突触可塑性。
J Neurosci. 2015 Aug 12;35(32):11190-5. doi: 10.1523/JNEUROSCI.0040-15.2015.
3
Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease.富含亮氨酸重复激酶2(LRRK2):帕金森病发病机制中的关键因子。
J Neurosci Res. 2009 May 1;87(6):1283-95. doi: 10.1002/jnr.21949.
4
Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.LRRK2 帕金森病运动前期的 5-羟色胺和多巴胺转运体 PET 变化:横断面研究。
Lancet Neurol. 2017 May;16(5):351-359. doi: 10.1016/S1474-4422(17)30056-X. Epub 2017 Mar 20.
5
Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity.帕金森病相关的G2019S LRRK2诱导的多巴胺能神经变性依赖于激酶和GTP酶活性。
Proc Natl Acad Sci U S A. 2020 Jul 21;117(29):17296-17307. doi: 10.1073/pnas.1922184117. Epub 2020 Jul 6.
6
Leucine-rich repeat kinase 2-related functions in GLIA: an update of the last years.富含亮氨酸重复激酶2在神经胶质细胞中的相关功能:近年研究进展
Biochem Soc Trans. 2021 Jun 30;49(3):1375-1384. doi: 10.1042/BST20201092.
7
Kinases and kinase signaling pathways: potential therapeutic targets in Parkinson's disease.激酶和激酶信号通路:帕金森病的潜在治疗靶点。
Prog Neurobiol. 2012 Aug;98(2):207-21. doi: 10.1016/j.pneurobio.2012.06.003. Epub 2012 Jun 16.
8
Dysregulated Wnt and NFAT signaling in a Parkinson's disease LRRK2 G2019S knock-in model.帕金森病 LRRK2 G2019S 敲入模型中失调的 Wnt 和 NFAT 信号。
Sci Rep. 2024 May 29;14(1):12393. doi: 10.1038/s41598-024-63130-8.
9
Leucine-Rich Repeat Kinase 2 in Parkinson's Disease: Updated from Pathogenesis to Potential Therapeutic Target.帕金森病中的富含亮氨酸重复激酶2:从发病机制到潜在治疗靶点的最新进展
Eur Neurol. 2018;79(5-6):256-265. doi: 10.1159/000488938. Epub 2018 Apr 27.
10
LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to .LRRK2 维持线粒体动态平衡,并调节对 的固有免疫反应。
Elife. 2020 Feb 14;9:e51071. doi: 10.7554/eLife.51071.

引用本文的文献

1
Mitigating neurodegenerative diseases: the protective influence of baicalin and baicalein through neuroinflammation regulation.减轻神经退行性疾病:黄芩苷和黄芩素通过调节神经炎症发挥的保护作用。
Front Pharmacol. 2024 Dec 2;15:1425731. doi: 10.3389/fphar.2024.1425731. eCollection 2024.

本文引用的文献

1
Diffusion tensor metrics, motor and non-motor symptoms in de novo Parkinson's disease.弥散张量指标与新发帕金森病的运动及非运动症状
Neuroradiology. 2024 Nov;66(11):1955-1966. doi: 10.1007/s00234-024-03452-6. Epub 2024 Aug 27.
2
Heme Oxygenase-1, Cardiac Senescence, and Myocardial Infarction: A Critical Review of the Triptych.血红素加氧酶-1、心脏衰老与心肌梗死:对三联症的批判性综述
Cardiovasc Drugs Ther. 2024 Jun 28. doi: 10.1007/s10557-024-07590-0.
3
Randomized controlled trial of intermittent hypoxia in Parkinson's disease: study rationale and protocol.
帕金森病间歇性低氧随机对照试验:研究原理和方案。
BMC Neurol. 2024 Jun 22;24(1):212. doi: 10.1186/s12883-024-03702-3.
4
The Protection of EGCG Against 6-OHDA-Induced Oxidative Damage by Regulating PPARγ and Nrf2/HO-1 Signaling.表没食子儿茶素没食子酸酯通过调节过氧化物酶体增殖物激活受体γ和核因子E2相关因子2/血红素加氧酶-1信号通路对6-羟基多巴胺诱导的氧化损伤的保护作用
Nutr Metab Insights. 2024 May 25;17:11786388241253436. doi: 10.1177/11786388241253436. eCollection 2024.
5
The Role of Oxygen Homeostasis and the HIF-1 Factor in the Development of Neurodegeneration.氧平衡和 HIF-1 因子在神经退行性变中的作用。
Int J Mol Sci. 2024 Apr 23;25(9):4581. doi: 10.3390/ijms25094581.
6
Detrimental Roles of Hypoxia-Inducible Factor-1α in Severe Hypoxic Brain Diseases.缺氧诱导因子-1α在重度缺氧性脑病中的有害作用
Int J Mol Sci. 2024 Apr 18;25(8):4465. doi: 10.3390/ijms25084465.
7
α-Synuclein: A Promising Biomarker for Parkinson's Disease and Related Disorders.α-突触核蛋白:帕金森病及相关疾病的一种有前景的生物标志物。
J Mov Disord. 2024 Apr;17(2):127-137. doi: 10.14802/jmd.24075. Epub 2024 Apr 9.
8
Hypoxia inducible factor-1α regulates microglial innate immune memory and the pathology of Parkinson's disease.缺氧诱导因子-1α 调节小胶质细胞固有免疫记忆和帕金森病的病理。
J Neuroinflammation. 2024 Mar 30;21(1):80. doi: 10.1186/s12974-024-03070-2.
9
Significance of dysautonomia in Parkinson's Disease and atypical parkinsonisms.自主神经功能障碍在帕金森病和非典型帕金森综合征中的意义。
Neurol Neurochir Pol. 2024;58(2):147-149. doi: 10.5603/pjnns.98678. Epub 2024 Mar 19.
10
Potential Impact of Hypoxic Astrocytes on the Aggravation of Depressive Symptoms in Parkinson's Disease.缺氧星形胶质细胞对帕金森病抑郁症状加重的潜在影响。
J Mol Neurosci. 2024 Mar 5;74(1):28. doi: 10.1007/s12031-024-02204-8.